Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 10,220

Document Document Title
WO/2009/147217A1
The present invention relates to compounds of formula (I) below in which: - R1 and R3 represent, independently of one another, a methoxy group optionally substituted by one or more fluorine atoms, - R2 and R4 represent, independently of ...  
WO/2009/146539A1
Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity are disclosed. Specifically, a series of compounds containing 4-(aminome...  
WO/2009/144179A1
The present invention relates to the compound L-menthyl-N-(2-hydroxyphenyl)carbamate, which is effective against body perspiration odor bacteria, in particular against armpit perspiration odor bacteria, and simultaneously effective as an...  
WO/2009/141170A3
The invention relates to a compound suited as entity carrier, having the general formula (I), wherein X is an amine-containing residue further defined herein. The invention further relates to the use of such compounds, a nanocarrier syst...  
WO/2009/141170A2
The invention relates to a compound suited as entity carrier, having the general formula (I), wherein X is an amine-containing residue further defined herein. The invention further relates to the use of such compounds, a nanocarrier syst...  
WO/2009/141079A1
The invention relates to compounds and the synthesis of [F-18] labelled L-glutamic acid and [F- 18] labelled L-glutamate, to their derivatives according to formula (I) and to the uses thereof.  
WO/2009/141079A8
The invention relates to compounds and the synthesis of [F-18] labelled L-glutamic acid and [F- 18] labelled L-glutamate, to their derivatives according to formula (I) and to the uses thereof.  
WO/2009/139061A1
This invention provides a production process which, in producing an isocyanate without using phosgene, is free from various problems as seen in the prior art and can stably produce the isocyanate at a high yield for a long period of time...  
WO/2009/139373A1
Disclosed is a compound useful as an active ingredient of a pharmaceutical composition, such as a pharmaceutical composition for treating chronic renal failure and/or diabetic nephropathy. Extensive studies are made for the purpose of fi...  
WO/2009/138416A1
The present invention relates to new oxime carbamoyl derivatives of formula (I), processes for their preparation, and to pharmaceutical compositions containing them for the treatment of neurological disorders, such as neuropathic pain an...  
WO/2009/136365A1
The present invention relates to a process for the preparation of threo-3,4-epoxy-2- amino-1-substituted butane derivatives represented by general Formula I which comprises reacting compound of Formula III or salt thereof with an active ...  
WO/2009/130534A1
This invention relates to a process for synthesizing Atazanavir, Formula (I), including novel intermediates and novel steps to various intermediates along the synthetic pathway.  
WO/2009/129938A1
The present invention relates to substituted phenoxybenzamide compounds of general formula (I) : in which R1, R2, R3, R4, R5, X, R6 and q are as defined in the claims, to methods of preparing said compounds, to pharmaceutical composition...  
WO/2009/129181A1
This disclosure relates to novel propanediol-dicarbamates, their derivatives, pharmaceutically acceptable salts thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions...  
WO/2009/129532A1
Compounds useful for promoting lysosomal processes and thereby ameliorating the disruption of cellular and functional integrity induced by Aβ and other protein and glycoconjugate species are provided. Methods for the treatment of neurod...  
WO/2009/129387A3
Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.  
WO/2009/129387A2
Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.  
WO/2009/119858A1
Disclosed is a novel benzene compound which has an excellent immunosuppressing activity, an excellent rejection-inhibiting effect and others, and is reduced in adverse side effects including bradycardia. Specifically disclosed is a compo...  
WO/2009/115537A8
The invention provides metal carbamates of the general formula (I) where R1 and R2 are each an alkyl group.  
WO/2009/115538A1
The object of the invention is a method for producing urethanes through reaction of aromatic amines with a dialkyl carbonate, characterized in that the alkyl radical of the organic dialkyl carbonate has 2-18 carbon atoms and the reaction...  
WO/2009/115539A1
The object of the invention is metal carbamates of the general formula (I), where R1 and R2 are equal or different, and are an alkyl group with 1-18 carbon atoms and where M is an alkali metal atom.  
WO/2009/117095A1
The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are...  
WO/2009/115537A1
The invention provides metal carbamates of the general formula (I) where R1 and R2 are each an alkyl group.  
WO/2009/113608A1
Provided is a process by which a urethane (meth)acrylate can be safely produced with satisfactory productivity. The process is a continuous process for urethane (meth)acrylate production which comprises causing a liquid mixture of a comp...  
WO/2009/110859A1
A pharmaceutically-acceptable modulator of the structure, activity, or expression level of an enzyme complex, such as the pyruvate dehydrogenase (PD) complex, in the mitochondria of warm-blooded animals, including humans, and methods of ...  
WO/2009/109973A3
The present invention relates to novel fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as agents for the treat...  
WO/2009/109504A1
The invention provides novel enol carbamate derivatives of formula (I) for inhibiting Fatty Acid Amide Hydrolase (FAAH), compositions that include such compounds as well as methods of treating diseases of energy metabolism, central nervo...  
WO/2009/109973A2
The present invention relates to novel fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as agents for the treat...  
WO/2009/106237A2
The present invention pertains to a catalyst for the synthesis of organic alkyl carbamates, the method for preparing the same and the use thereof. The catalyst comprises a catalytically active component and a catalyst support, and the ca...  
WO/2009/106237A3
The present invention pertains to a catalyst for the synthesis of organic alkyl carbamates, the method for preparing the same and the use thereof. The catalyst comprises a catalytically active component and a catalyst support, and the ca...  
WO/2009/108484A1
The present invention provides novel synthesis's for obtaining a protecting group aminoxy PEG-6 linker from cost effective, and readily available starting materials and chemicals or modified polyethylene glycols. More specifically, a nov...  
WO/2009/098327A1
Method for producing fluorinated carbamates that comprises the reaction between an amine or polyamine and a fluorinated carbonate in the presence of a catalyst in the presence of basic heterogeneous catalysts. The method may also compris...  
WO/2009/096545A1
A diurethane compound R2(SO2)m(CH2)nOCONH-R1-NHCOO(CH2)n(SO2)mR2 is produced by a method in which a diamine compound H2NR1NH2 is reacted with a chloroformate compound ClCOO(CH2)n(SO2)mR2 or by a method in which a diisocyanate compound OC...  
WO/2009/095164A1
The invention relates to a method for producing urethanes by the oxidative carbonylation of amino compounds in the presence of carbon monoxide, oxygen and organic compounds carrying hydroxyl groups, characterized in that the carbonylatio...  
WO/2009/095324A1
The present invention provides novel compounds of the general formula (I), and pharmaceutically acceptable salts thereof, processes for the manufacture of these novel compounds and medicaments, containing them. The compounds of the prese...  
WO/2009/094563A2
A crystalline form of Ca-salts of (3S) -aminomethyl-5-hexanoic acids and methods of preparing a crystalline form of a (3S) -aminomethyl-5-hexanoic acid and methods of using a crystalline form of a (3S) -aminomethyl-5-hexanoic acid are pr...  
WO/2009/094577A2
Mesophasic forms of Ca-salts of (3S) -aminomethyl-5-hexanoic acids and methods of preparing and methods of using mesophasic forms of (3S) -aminomethyl-5-hexanoic acids are provided.  
WO/2009/094569A3
Methods of enzymatically resolving acyloxyalkyl thiocarbonates useful in the synthesis of acyloxyalkyl carbamates are disclosed. These carbamates can be coupled to drugs containing amines such as R-baclofen or S-pregabalin.  
WO/2009/094577A3
Mesophasic forms of Ca-salts of (3S) -aminomethyl-5-hexanoic acids and methods of preparing and methods of using mesophasic forms of (3S) -aminomethyl-5-hexanoic acids are provided.  
WO/2009/094563A3
A crystalline form of Ca-salts of (3S) -aminomethyl-5-hexanoic acids and methods of preparing a crystalline form of a (3S) -aminomethyl-5-hexanoic acid and methods of using a crystalline form of a (3S) -aminomethyl-5-hexanoic acid are pr...  
WO/2009/094569A2
Methods of enzymatically resolving acyloxyalkyl thiocarbonates useful in the synthesis of acyloxyalkyl carbamates are disclosed. These carbamates can be coupled to drugs containing amines such as R-baclofen or S-pregabalin.  
WO/2009/090251A2
The invention relates to a process for producing NEP inhibitors or prodrugs thereof, in particular NEP inhibitors comprising a γ-amino-δ-biphenyl-α-methylalkanoic acid, or acid ester, backbone. In detail, the new processes, according ...  
WO/2009/090251A3
The invention relates to a process for producing NEP inhibitors or prodrugs thereof, in particular NEP inhibitors comprising a γ-amino-δ-biphenyl-α-methylalkanoic acid, or acid ester, backbone. In detail, the new processes, according ...  
WO/2009/089022A1
The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for det...  
WO/2009/087682A3
The present invention relates to an injectable pregabalin formulation which is stable in between pH 4.0 to 8.0. Further, the present invention relates to a process for manufacturing the said injectable pregabalin formulation. The injecta...  
WO/2009/086705A1
The present invention provides N-methylethylcarbamino-3-[(S)-1-(methyl-[(S) -1-phenylethyl] amino) ethyl] phenyl ester of formula (II) and its preparation method. The present invention also provides (S)-1-(3-methoxyphenyl)-N-methyl-N-[(S...  
WO/2009/088834A3
A compound, oligomer, or polymer having a functional group of formula (I) wherein R is a group having 1 to 12 carbons and optionally including one or more heteroatoms selected from oxygen, nitrogen, and sulfur is useful in curable compos...  
WO/2009/089192A1
The present invention provides novel phenoxyacetic acids useful for the prevention and treatment of inflammatory disorders, including those affecting the respiratory system and skin. The compounds are of the general formula (I):  
WO/2009/088834A2
A compound, oligomer, or polymer having a functional group of formula (I) wherein R is a group having 1 to 12 carbons and optionally including one or more heteroatoms selected from oxygen, nitrogen, and sulfur is useful in curable compos...  
WO/2009/087981A1
Disclosed is a polymerizable compound which can be obtained by a simpler process. The polymerizable compound is represented by formula (1) or (2). [Rf-{R1-X0-(CO)t-R2-}q]mX1-R3-Z (1) Rf-R1-X2-CO(NH)r-R3-Z (2) In the formulae, Rf represen...  

Matches 551 - 600 out of 10,220